News Articles Tagged: SGLT Inhibitors

Navigating the Synthesis of SGLT Inhibitors: The Importance of High-Purity Thiophene Intermediates

Delve into the synthetic pathways for SGLT inhibitors, highlighting the critical role of intermediates like 2-(4-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene. Learn about quality and sourcing.

The Crucial Role of 2-(4-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene in Modern Drug Development

Explore how this key pharmaceutical intermediate, CAS 898566-17-1, is driving innovation in SGLT inhibitor synthesis and other advanced chemical applications. Learn about its properties and sourcing.

The Role of Sotagliflozin (LX-4211) in Heart Failure Risk Reduction

Discover how Sotagliflozin (LX-4211) contributes to reducing the risk of cardiovascular events and heart failure hospitalization.

Sotagliflozin for Diabetes: A Dual SGLT Inhibitor Approach

Examine how Sotagliflozin (LX-4211), as a dual SGLT inhibitor, offers a unique approach to managing type 2 diabetes.

Exploring the In Vivo Activity of Sotagliflozin (LX-4211)

An in-depth look at the in vivo activity of Sotagliflozin (LX-4211), detailing its effects in animal models and its implications for human health.

Sotagliflozin (LX-4211): Chemical Properties and Research Applications

Delve into the essential chemical properties of Sotagliflozin (LX-4211) and explore its diverse applications in pharmaceutical research and development.

Understanding the Mechanism of Action of Sotagliflozin (LX-4211)

Explore the intricate mechanism of action of Sotagliflozin (LX-4211), a dual SGLT1/SGLT2 inhibitor, and its implications for diabetes and cardiovascular health.